OPCH

McKesson Corporation (NYSE:MCK) is expanding its specialty healthcare operations through a $5.8 billion acquisition (including debt) of Option Care Health, Inc. (NASDAQ:OPCH), partnering with private equity firm Clayton, Dubilier & Rice to take the…

Option Care Health (NasdaqGS:OPCH) faces shareholder investigations into its proposed sale to Clayton, Dubilier & Rice and McKesson Corporation.

Option Care Health shares have jumped into focus after a sharp move higher and a US$5.8b buyout agreement, which raises a straightforward question for investors who care about valuation.

McKesson is taking 49% of Option Care as more complex infusion treatments shift to homes and outpatient sites.

Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Shares of alternate site health provider Option Care Health (NASDAQ:OPCH) jumped 33.2% in the pre-market session after Financial Times reported that McKesson and Clayton Dubilier & Rice are nearing a transaction valued at more than $5 billion to acquire the…

Option Care Health Inc. (NASDAQ:OPCH) soared by as much as 33 percent on Tuesday to $31.11 apiece following news that it is merging with Clayson, Dubilier, & Rice LLC (CD&R) and McKesson Corp. for $5.8 billion.

The provider of home and alternate site infusion services is being acquired.

Drug distributor McKesson (MCK) and private investment firm Clayton Dubilier & Rice agreed to acquir

Option Care Health has agreed to be acquired by CD&R and McKesson for $32. 05 per share in cash, representing approximately $5.

A deal would value the infusion provider at more than $5 billion.